US SB2198 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 22 2023 - 25% progression, died in committee
Action: 2023-06-22 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 22 2023 - 25% progression, died in committee
Action: 2023-06-22 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Title
Prescription Drug Supply Chain Pricing Transparency Act
Sponsors
| Sen. Michael Bennet [D-CO] | Sen. James Lankford [R-OK] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-22 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
SB2973 (Related) 2023-12-07 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 266.
HB7535 (Same As) 2024-03-08 - Referred to the Subcommittee on Health.
HB7535 (Same As) 2024-03-08 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/2198/all-info |
| Text | https://www.congress.gov/118/bills/s2198/BILLS-118s2198is.pdf |
